quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·576d
PRRelease
Aligos Therapeutics Inc. logo
Haemonetics Corporation logo
Novo Nordisk A/S logo
+2

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

ALGS· Aligos Therapeutics Inc.HAE· Haemonetics CorporationNVO· Novo Nordisk A/SPLRX· Pliant Therapeutics Inc.DRNA· Dicerna Pharmaceuticals, Inc.
Health Care
Original source

Companies

  • ALGS
    Aligos Therapeutics Inc.
    Health Care
  • HAE
    Haemonetics Corporation
    Health Care
  • NVO
    Novo Nordisk A/S
    Health Care
  • PLRX
    Pliant Therapeutics Inc.
    Health Care
  • DRNA
    Dicerna Pharmaceuticals, Inc.
    Health Care

Recent analyst ratings

  • Mar 26NVOUpdateWolfe Research-
  • Mar 19ALGSUpdateJefferies$48.00
  • Mar 18NVOUpdateBernstein-
  • Mar 18NVOUpdateBernstein$175.00
  • Mar 10NVOUpdateTD Cowen$42.00
  • Mar 3NVOUpdateMorgan Stanley$40.00

Related

  • PR19h
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • SEC1d
    SEC Form DEFA14A filed by Pliant Therapeutics Inc.
  • SEC1d
    SEC Form DEF 14A filed by Pliant Therapeutics Inc.
  • SEC2d
    SEC Form 8-K filed by Aligos Therapeutics Inc.
  • SEC3d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC3d
    SEC Form 6-K filed by Novo Nordisk A/S
  • PR5d
    Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
  • INSIDER6d
    SEC Form 4 filed by Kuo Minnie
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022